Melissa Glassford, DNP, discusses clinical strategies for managing GLP-1 therapy gaps, dose titration, weight plateaus, and ...

Novo Nordisk will discontinue its weight loss medication Saxenda in January 2027. People who currently take Saxenda for ...

Emily McNutt is a journalist and editorial leader with extensive experience covering a range of topics from travel rewards to product reviews and financial news. With a passion for accurate reporting ...

Effectiveness of Saxenda vs. Victoza Saxenda is approved to help with long-term weight loss in people with overweight or obesity. Victoza is approved to help manage blood sugar levels in adults with ...

Saxenda, which is injected daily, is the only form of GLP-1 therapy which is reimbursed for weight loss by the HSE, free ...

The percentage of American adults who are currently taking a GLP-1 drug for weight loss is 11%, according to a new survey from Gallup. That’s up from 8% in 2025 and 3% in 2024, according to the ...

In Australia, GLP-1 weight loss drugs are generally prescribed for chronic weight management in adults with a body mass index ...